| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |